Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is a non-profit organization that assists patients without adequate financial resources and prescription coverage obtain free products donated by Johnson & Johnson operating companies.

The Foundation is an independent organization reflecting the Johnson & Johnson operating companies’ long-standing commitment to helping patients access medicines.

Donor Companies

  • Janssen Biotech, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Janssen Therapeutics, Division of Janssen Products, LP
  • DePuy Synthes Mitek Sports Medicine, a division of DePuy Orthopaedics, Inc.​​

How to Apply

Please either download the application below (if available) or go to the program website for more information on how to apply. Once you fill out your application, send it to the address on the application. Remember not to send program applications to PPA.

Product(s) Covered by Program

  • D

    • DARZALEX® (daratumumab) Injection for intravenous infusion
    • DOXIL® (doxorubicin HCl liposome) IV Infusion
  • E

    • EDURANT®
    • ELMIRON® (pentosan polysulfate sodium) Capsules
    • ERLEADA™ (apalutamide) Tablets
  • H

    • HALDOL® (haloperidol) Immediate-Release Formulation Injection
    • HALDOL® Decanoate (haloperidol) IM Injection Only
  • I

    • IMBRUVICA® (ibrutinib) Capsules
    • INVEGA SUSTENNA® (paliperidone palmitate) Extended-Release Injectable Suspension
    • INVOKAMET® (canagliflozin/metformin HCI) Tablets
    • INVOKAMET® XR Extended-Release Tablets
    • INVOKANA® (canagliflozin) Tablets
  • M

    • MONOVISC® (high molecular weight hyaluronan) Injection
  • O

    • ORTHOVISC® (high molecular weight hyaluronan) Injection
  • P

    • PANCREAZE® (pancrelipase) Delayed-Release Capsules
    • PREZCOBIX® (darunavir 800mg/cobicistat 150mg) Tablets
    • Prezista®
    • PROCRIT® (epoetin alfa) Injection
  • R

    • REMICADE® (infliximab) for IV Injection
    • RISPERDAL CONSTA® (risperidone) Long-Acting Injection
  • S

    • SIMPONI ARIA® (golimumab) IV Infusion
    • SIMPONI® (golimumab) Injection
    • SIRTURO® (bedaquiline) Tablets
    • SPORANOX® (itraconazole) Capsules
    • SPORANOX® (itraconazole) Oral Solution
    • STELARA® (ustekinumab) Injection
    • SYLVANT® (siltuximab) IV Infusion
  • T

    • TREMFYA™ (guselkumab) Injection, for subcutaneous use
  • X

    • XARELTO® (rivaroxaban) Tablets
  • Y

    • YONDELIS® (trabectedin) Injection for intravenous infusion
  • Z

    • ZYTIGA® (abiraterone acetate) Tablets